Mankind Pharma has completed the acquisition of Bharat Serums and Vaccines Ltd for Rs 13,768 crore. This acquisition strengthens Mankind Pharma's position in the Indian women's health and fertility drug market. The transaction aligns with Mankind's strategy to access high entry barrier products and complex R&D platforms, promising accelerated growth and expanded market access.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.